Non-Interventional Observational Study With Viramune Plus ARV in HIV Infected Patients.

Trial Profile

Non-Interventional Observational Study With Viramune Plus ARV in HIV Infected Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jan 2015

At a glance

  • Drugs Nevirapine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine/abacavir; Lamivudine/zidovudine
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov.
    • 07 Mar 2012 Planned end date changed from 1 Dec 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top